Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Primary Central Nervous System Lymphoma (PCNSL) is a highly malignant brain tumour. We investigated dynamic changes in tumour volume and apparent diffusion coefficient (ADC) measurements for predicting outcome following treatment with MATRix chemotherapy in PCNSL. Patients treated with MATRix (<i...

Full description

Bibliographic Details
Main Authors: Isabel Cornell, Ayisha Al Busaidi, Stephen Wastling, Mustafa Anjari, Kate Cwynarski, Christopher P. Fox, Nicolas Martinez-Calle, Edward Poynton, John Maynard, Steffi C. Thust
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Personalized Medicine
Subjects:
CNS lymphoma
MATRix
response imaging
Online Access:https://www.mdpi.com/2075-4426/13/7/1182

Internet

https://www.mdpi.com/2075-4426/13/7/1182

Similar Items